Daniel Gomez, MD

Disclosure:
Employment
MD Anderson Cancer Center - Proton Therapy Center: Associate Professor: Employee

Compensation
AstraZeneca: Advisory Board, Research Grants; BMS: Honoraria; Driver: Travel Expenses; Elekta: Travel Expenses; Merck: Research Grants, Speaker's Bureau; Reflexion: Honoraria; Varian: Speaker's Bureau

Presentation(s):

• LBA3 - Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial

  Sunday, October 21
  4:15 PM – 4:25 PM

• eContouring for Lung Cancer

  Monday, October 22
  11:05 AM – 11:25 AM